Shareholders' Equity (Details) |
1 Months Ended | 12 Months Ended | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jul. 08, 2020
USD ($)
$ / shares
shares
|
Jun. 12, 2020
USD ($)
$ / shares
shares
|
Mar. 09, 2020
USD ($)
$ / shares
shares
|
Feb. 12, 2020
USD ($)
$ / shares
shares
|
Jan. 09, 2020
USD ($)
$ / shares
shares
|
Jan. 09, 2020
USD ($)
$ / shares
shares
|
Dec. 20, 2021
USD ($)
$ / shares
shares
|
Aug. 16, 2021
USD ($)
$ / shares
shares
|
Mar. 31, 2021
USD ($)
shares
|
Feb. 28, 2021
USD ($)
shares
|
Dec. 31, 2020
shares
|
May 31, 2020
USD ($)
$ / shares
shares
|
Apr. 30, 2020
USD ($)
$ / shares
shares
|
Apr. 28, 2020
₪ / shares
shares
|
Dec. 31, 2022
$ / shares
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2020
USD ($)
shares
|
Feb. 22, 2023
₪ / shares
|
Nov. 28, 2013
shares
|
|
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||
| Par value (in New Shekels per share) | (per share) | ₪ 5,000,000,000 | ||||||||||||||||||
| Purchase aggregate warrant | 228,192,286 | 375,197,640 | 377,947,640 | 228,192,286 | |||||||||||||||
| Exercise price (in Dollars per share) | $ / shares | $ 0.08 | $ 0.08 | $ 0.11 | $ 0.07 | |||||||||||||||
| Ordinary share issued per share (in Dollars) | $ | $ 2.625 | $ 2.625 | |||||||||||||||||
| Issuance cost (in Dollars) | $ | 0.1 | ||||||||||||||||||
| Gross proceeds (in Dollars) | $ | $ 3,400,000 | $ 8,000,000 | $ 1,012,000 | $ 2,400,000 | $ 10,000,000 | $ 10,000,000 | $ 1,550,000 | $ 1,550,000 | $ 75,000 | ||||||||||
| Issue of new unregistered warrants | 25,582,500 | 22,278,540 | |||||||||||||||||
| Deemed dividend (in Dollars) | $ | $ 715,000 | ||||||||||||||||||
| Securities purchase agreement, description | the Company completed a public offering with certain institutional investors pursuant to which the Company issued and sold (i) 54,750,000 units, each unit consisting of one Ordinary share, and one warrant to purchase one Ordinary share, at a price of $ 0.05 per unit, and (ii) 45,250,020 pre-funded units each pre-funded unit consisting of one pre-funded warrant to purchase one Ordinary share and one warrant, at a price of $ 0.05 per pre-funded unit. | ||||||||||||||||||
| Gross proceeds from offering (in Dollars) | $ | $ 5,000,000 | ||||||||||||||||||
| Expiring date | Feb. 10, 2025 | ||||||||||||||||||
| Ordinary shares issued | 20,250,000 | 1,050,000 | |||||||||||||||||
| Increase authorized capital | 1,000,000,000 | ||||||||||||||||||
| Aggregate warrant | 31,000,020 | 31,000,020 | |||||||||||||||||
| Sold an aggregate shares | 5,947 | 5,947 | |||||||||||||||||
| Aggregate number of ADS percentage | 7.50% | ||||||||||||||||||
| Warrants to purchase aggregate ADS shares | 3,837,390 | ||||||||||||||||||
| Exercise price (in Dollars per share) | $ / shares | $ 0.08 | ||||||||||||||||||
| Ordinary shares | 1,350,000 | 93,000,000 | |||||||||||||||||
| Total consideration amount (in Dollars) | $ | $ 2,744,000 | $ 2,744,000 | |||||||||||||||||
| Exchange services (in Dollars) | $ | $ 68,000 | ||||||||||||||||||
| Offering price (in Dollars per share) | $ / shares | $ 0.07 | ||||||||||||||||||
| Pre-funded warrant (in Dollars per share) | $ / shares | $ 0.06 | ||||||||||||||||||
| Aggregate number of ADS percentage (in Dollars) | $ | $ 9,997,000 | ||||||||||||||||||
| Issuance expenses (in Dollars) | $ | $ 1,307,000 | ||||||||||||||||||
| Ordinary shares issued | 300 | ||||||||||||||||||
| Initial exercise price per share (in Dollars per share) | $ / shares | $ 0.07 | ||||||||||||||||||
| Stock issuance agreement, description | On December 20, 2021, the Company entered into a warrant exercise agreement (the “Exercise Agreement”) with an institutional investor who is the holder of certain existing warrants to purchase Company’s ordinary shares in a registered direct offering consummated in August 2021. | ||||||||||||||||||
| Aggregate shares | 150,000,000 | ||||||||||||||||||
| Exercise agreement description | The Private Placement Warrants will be immediately exercisable, will expire five years following the effectiveness of an initial resale registration statement registering the ADSs issuable upon the exercise of the warrants, and have an exercise price of $0.07 per Ordinary share. The Company also paid $875 in placement agent fees and issued unregistered placement agent warrants to purchase 10,500,000 Ordinary shares on the same terms as the warrant. Pursuant to the terms of the Exercise Agreements, the holder agreed to exercise the warrants while receiving a-120% warrants coverage, thereby creating a benefit to this warrant holder. As such, the Company recorded a deemed dividend in the amount of $ 2,590. | ||||||||||||||||||
| ADS [Member] | |||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||
| Purchase aggregate warrant | 22,278,540 | 22,278,540 | 700,000 | ||||||||||||||||
| Exercise price (in Dollars per share) | $ / shares | $ 0.06 | $ 0.07 | |||||||||||||||||
| Issue of new unregistered warrants | 51,165,000 | 58,536,600 | |||||||||||||||||
| Warrants exercisable | 1,559,498 | 1,559,498 | |||||||||||||||||
| Compensation warrant exercisable | 7,500,000 | ||||||||||||||||||
| Exercise prices (in Dollars per share) | $ / shares | $ 0.08 | $ 0.0625 | |||||||||||||||||
| Ordinary per share issued (in Dollars per share) | $ / shares | $ 0.05 | ||||||||||||||||||
| Aggregate warrant | 8,780,490 | 150,000,000 | 57,000,000 | ||||||||||||||||
| Exercise price subject to adjustment (in Dollars per share) | $ / shares | $ 0.05 | $ 0.05 | |||||||||||||||||
| Sold an aggregate shares | 117,073,200 | 57,000,000 | |||||||||||||||||
| Ordinary Shares [Member] | |||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||
| Exercise price (in Dollars per share) | $ / shares | $ 0.43 | ||||||||||||||||||
| Gross proceeds (in Dollars) | $ | |||||||||||||||||||
| Ordinary shares issued | 93,000,000 | 1,350,000 | |||||||||||||||||
| Ordinary per share issued (in Dollars per share) | $ / shares | $ 0.07 | ||||||||||||||||||
| Ordinary shares | 180,000,000 | 50,926,830 | 50,926,830 | ||||||||||||||||
| Ordinary shares issued | 10,500,000 | 35,000,000 | |||||||||||||||||
| Aggregate shares | 1,050,000 | ||||||||||||||||||
| Minimum [Member] | |||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||
| Exercise price (in Dollars per share) | $ / shares | $ 0.018 | ||||||||||||||||||
| Minimum [Member] | ADS [Member] | |||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||
| Exercise prices (in Dollars per share) | $ / shares | $ 980,000 | ||||||||||||||||||
| Private Placement Warrants [Member] | ADS [Member] | |||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||
| Exercise price (in Dollars per share) | $ / shares | $ 0.11 | ||||||||||||||||||
| Subsequent Event [Member] | |||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||
| Par value (in New Shekels per share) | ₪ / shares | ₪ 0.25 | ||||||||||||||||||